the aim of the present study was to investigate the effect of a new galenic injectable form of bromocriptine ( parlodel la ) , characterized by sustained release of bromocriptine for 4-6 weeks , in 3 patients with prolactin-secreting macroadenomas through a 42-day follow-up .
C0033371
prolactin
C1327616
secreting